These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 15450280

  • 1. Atrial fibrillation and cardiac resynchronization therapy: the MASCOT study.
    Padeletti L, Musilli N, Porciani MC, Colella A, Di Biase L, Ricciardi G, Pieragnoli P, Michelucci A, Gensini G.
    Europace; 2004 Sep; 5 Suppl 1():S49-54. PubMed ID: 15450280
    [Abstract] [Full Text] [Related]

  • 2. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G, Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [Abstract] [Full Text] [Related]

  • 3. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC, Casares JM, Eiskjaer H, Hagemann A, Cleland JG, Freemantle N, Erdmann E.
    Circulation; 2006 Jul 04; 114(1):18-25. PubMed ID: 16801461
    [Abstract] [Full Text] [Related]

  • 4. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E, Saba S.
    Am Heart J; 2008 Jan 04; 155(1):94-9. PubMed ID: 18082497
    [Abstract] [Full Text] [Related]

  • 5. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure.
    Delnoy PP, Ottervanger JP, Luttikhuis HO, Elvan A, Misier AR, Beukema WP, van Hemel NM.
    Am J Cardiol; 2007 May 01; 99(9):1252-7. PubMed ID: 17478153
    [Abstract] [Full Text] [Related]

  • 6. Dynamic and dual-site atrial pacing in the prevention of atrial fibrillation: The STimolazione Atrial DInamica Multisito (STADIM) Study.
    De Simone A, Senatore G, Donnici G, Turco P, Romano E, Gazzola C, Stabile G.
    Pacing Clin Electrophysiol; 2007 Jan 01; 30 Suppl 1():S71-4. PubMed ID: 17302722
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiac resynchronization therapy in patients with chronic atrial fibrillation.
    Zankar A, Joglar JA, Naseem RH.
    Cardiol Rev; 2007 Jan 01; 15(6):310-5. PubMed ID: 18090067
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA, Greenfield RA, Crandall BG, Nydegger CC, Orlov M, VAN Genderen R.
    J Cardiovasc Electrophysiol; 2006 May 01; 17(5):520-5. PubMed ID: 16684026
    [Abstract] [Full Text] [Related]

  • 13. Cardiac resynchronization therapy response is associated with shorter duration of atrial fibrillation.
    Lellouche N, De Diego C, Vaseghi M, Buch E, Cesario DA, Mahajan A, Wiener I, Fonarow GC, Boyle NG, Shivkumar K.
    Pacing Clin Electrophysiol; 2007 Nov 01; 30(11):1363-8. PubMed ID: 17976100
    [Abstract] [Full Text] [Related]

  • 14. Atrial fibrillation burden during the post-implant period after crt using device-based diagnostics.
    Hügl B, Bruns HJ, Unterberg-Buchwald C, Grosse A, Stegemann B, Lauer B, Geller JC, Gasparini M.
    J Cardiovasc Electrophysiol; 2006 Aug 01; 17(8):813-7. PubMed ID: 16903958
    [Abstract] [Full Text] [Related]

  • 15. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study.
    Sulke N, Silberbauer J, Boodhoo L, Freemantle N, Kamalvand K, O'Nunain S, Hildick-Smith D, Lloyd GW, Patel NR, Paul V.
    Europace; 2007 Sep 01; 9(9):790-7. PubMed ID: 17562750
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.